Sandoval LD, Villalobos MC, Sequeira CD, Murillo SJA, Sánchez MES

Language: Spanish
References: 8
Page: 8-13
PDF size: 427.56 Kb.

ABSTRACT

Atrial fibrillation (AF) is the most common cardiac arrhythmia. The chance of developing atrial fibrillation is tied closely to age, this pathology is rare before the age of 50 years. In addition to age, there are many types of cardiac and medical conditions that are also closely linked to AF.
Atrial fibrillation is an independent risk factor for cerebrovascular disease, which involves an increase in risk of approximately 3 to 5 times in patients who do not receive anticoagulation therapy. That is why management with preventive treatment plays a vital role.

REFERENCES

1. Corbalán R. Fibrilación auricular no valvular y anticoagulación. Revista Uruguaya de Cardiología, Scielo,2018; 30: 1-7.

2. Longo D Fauci A Kasper D et al. Harrison´s Priciples of Internal Medicine, 18th Ed. Mc Graw Hill, 2012; 1881 - 1885

3. Kumar K. Overview of atrial fibrillation. UpToDate. 2018.

4. Manning W Singer D. Atrial fibrillation: Risk of embolization. UpToDate. 2018.

5. Lip G. Mechanisms of thrombogenesis in atrial fibrillation. UpToDate 2017.

6. Manning W Singer D Lip G. Atrial fibrillation: Anticoagulant therapy to prevent embolization. UpTo- Date 2018.

7. Hilial R Brunton L. Goodman and Gilman Manual de farmacología y Terapéutica. Mc Graw Hill, 2015;561 – 570.

8. Jaramillo R Jiménez J Pinilla A. Uso de los anticoagulantes orales directos en la práctica clínica. Revista de la Facultad de Medicina, Scielo,2016; 64(2): 3-6